EcoDrugPlus

Ribosomal Protein L10a

Ensembl ID : ENSMZEG00005002010
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSMZEG00005026109
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSMZEG00005003093
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSMZEG00005014343
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSMZEG00005004952
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSMZEG00005017031
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSMZEG00005023287
Gene Symbol: RPL17
3 Cross references
710 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSMZEG00005018966
Gene Symbol: RPL18A
3 Cross references
367 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSMZEG00005021908
Gene Symbol: RPL21
3 Cross references
784 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMZEG00005000812
Gene Symbol: RPL22
3 Cross references
199 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMZEG00005007093
Gene Symbol: RPL22
3 Cross references
208 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSMZEG00005000906
Gene Symbol: RPL23
3 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).